Eduardo Ricci Ricci-Júnior

Dr. Eduardo Ricci Ricci-Júnior

Drugs and Medicines, UFRJ, Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
TMTatiana Zanela da Silva Marques
Tatiana Zanela da Silva Marques
RSRalph Santos-Oliveira
Ralph Santos-Oliveira
LSLuciana Betzler de Oliveira de Siqueira
Luciana Betzler de Oliveira de Siqueira
VCVerônica da Silva Cardoso
Verônica da Silva Cardoso
ZFZaida Maria Faria de Freitas
Zaida Maria Faria de Freitas
EREduardo Ricci Ricci-Júnior
Eduardo Ricci Ricci-Júnior
Background: Propranolol (PPN) is a therapeutic option for the treatment of infantile hemangiomas. This study aimed at the development of nanoemulsion (NE) containing 1% PPN, characterization of the system, and safety studies based on ex vivo permeation, cytotoxicity, and biodistribution in vivo. Methods: The formulation was developed and characterized in relation to the droplet size, polydispersity index (PDI), pH, zeta potential, and electronic microscopy. Ex vivo permeation studies were used to evaluate the cutaneous retention of PPN in the epidermis and dermis. Cytotoxicity studies were performed in fibroblasts, macrophages, and keratinocytes. In vivo biodistribution assay of the formulations was performed by means of labeling with technetium-99m. Results: NE1 exhibited droplet size of 26 nm, PDI <0.4, pH compatible with the skin, and zeta potential of −20 mV, which possibly contributes to the stability. Electron microscopy showed that the NE presented droplets of nanometric size and spherical shape. NE1 provided excellent stability for PPN. In the ex vivo cutaneous permeation assay, the NE provided satisfactory PPN retention particularly in the dermis, which is the site of drug action. In addition, NE1 promoted cutaneous permeation of the PPN in small amount. In vivo biodistribution showed that the radiolabeled formulation remained in the skin and a small amount reached the bloodstream. NE1 presented low cytotoxicity to fibroblasts, macrophages, and keratinocytes in the concentrations evaluated in the cytotoxicity assay. Conclusion: We concluded that the formulation is safe for skin administration; however, cutaneous irritation studies should be performed to confirm the safety of the formulation before clinical studies in patients with infantile hemangiomas.

1 January 2011 in Química Nova
Verified
Journal Article
Open access
PDF file
VMVanessa Azevedo de Mello
Vanessa Azevedo de Mello
EREduardo Ricci Ricci-Júnior
Eduardo Ricci Ricci-Júnior
Nanoparticles were produced by solvent emulsification evaporation method with the following characteristics: nanometric size (238 ± 3 nm), narrow polydispersity index (0.11), negative zeta potential (-15.1 mV), good yield of the process (73 ± 1.5%), excellent encapsulation efficiency (81.3 ± 4.2%) and spherical shape. X-rays diffraction demonstrated the loss of drug crystallinity after encapsulation; however, the profile of the diffractograms of the poly-ε-caprolactone (PCL) nanoparticles was kept. Differential scanning calorimetry thermograms, correspondingly, exhibited the loss of drug melting peak and the increasing of the melting point of the PCL nanoparticles, evidencing an interaction drug-polymer. Naproxen release was low and sustained obeying the Higuchi´s kinetic. The results show that nanoparticles are promising sustained release system to the naproxen

1 October 2020 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
RSRaphaela Aparecida Schuenck-Rodrigues
Raphaela Aparecida Schuenck-Rodrigues
LSLuciana Betzler de Oliveira de Siqueira
Luciana Betzler de Oliveira de Siqueira
AMAna Paula dos Santos Matos
Ana Paula dos Santos Matos
SCSandro Pinheiro da Costa
Sandro Pinheiro da Costa
VCVerônica da Silva Cardoso
Verônica da Silva Cardoso
EREduardo Ricci Ricci-Júnior
Eduardo Ricci Ricci-Júnior

1 January 2020 in Brazilian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
MSMárcio Robert Mattos da Silva
Márcio Robert Mattos da Silva
LDLetícia Pereira Dysars
Letícia Pereira Dysars
ESElisabete Pereira dos Santos
Elisabete Pereira dos Santos
EREduardo Ricci Ricci-Júnior
Eduardo Ricci Ricci-Júnior
At the hospital, the pharmacist is constantly challenged to prepare extemporaneous solutions from tablets, capsules or drug powder for patients unable to swallow, such as pediatric, elderly and patients that use nasoenteric and nasogastric tubes. The preparation of extemporaneous solutions from capsules, tablets and drug powder requires stability studies analysis. This article is a bibliographic review of preparation of extemporaneous oral liquid from solid oral dosage forms used in clinical practice. The selected articles contain all the information regarding manipulation techniques, pharmaceutical excipients, packaging, storage conditions and results of stability studies above 90% performed by HPLC analysis. In addition, a situational analysis of the strategies for the preparation of the extemporaneous solution was described to help the manipulator in the decision. The preparation of extemporaneous solution from solid oral dosage forms is based on information from official compendium or scientific literature, to ensure safe and effective manipulated medicine.

Verified
Journal Article
Open access
PDF file
EHEdward Helal-Neto
Edward Helal-Neto
ABAline De Barros
Aline De Barros
RSRoberta Saldanha-Gama
Roberta Saldanha-Gama
RCRenata Costa
Renata Costa
LALuciana Alencar
Luciana Alencar
RSRalph Santos-Oliveira
Ralph Santos-Oliveira
Nanodrugs have in recent years been a subject of great debate. In 2017 alone, almost 50 nanodrugs were approved for clinical use worldwide. Despite the advantages related to nanodrugs/nanomedicine, there is still a lack of information regarding the biological safety, as the real behavior of these nanodrugs in the body. In order to better understand these aspects, in this study, we evaluated the effect of polylactic acid (PLA) nanoparticles (NPs) and magnetic core mesoporous silica nanoparticles (MMSN), of 1000 nm and 50 nm, respectively, on human cells. In this direction we evaluated the cell cycle, cytochemistry, proliferation and tubulogenesis on tumor cells lines: from melanoma (MV3), breast cancer (MCF-7, MDA-MB-213), glioma (U373MG), prostate (PC3), gastric (AGS) and colon adenocarcinoma (HT-29) and non-tumor cell lines: from human melanocyte (NGM), fibroblast (FGH) and endothelial (HUVEC), respectively. The data showed that an acute exposure to both, polymeric nanoparticles or MMSN, did not show any relevant toxic effects on neither tumor cells nor non-tumor cells, suggesting that although nanodrugs may present unrevealed aspects, under acute exposition to human cells they are harmless.

1 March 2021 in Materials Today Communications
Verified
Journal Article
Closed access
DFDiogo M. Fernandes
Diogo M. Fernandes
WBWagner S. Barbosa
Wagner S. Barbosa
WRWeslley S.P. Rangel
Weslley S.P. Rangel
IVIsabella Mourão M. Valle
Isabella Mourão M. Valle
AMAna Paula dos Santos Matos
Ana Paula dos Santos Matos
MMMariana Monteiro
Mariana Monteiro